Advertisement

Topics

Companies Related to "RegeneRx Biopharmaceuticals" [Most Relevant Company Matches] RSS

00:21 EDT 23rd July 2018 | BioPortfolio

Here are the most relevant search results for "RegeneRx Biopharmaceuticals" found in our extensive corporate database of over 50,000 company records.

Showing "RegeneRx Biopharmaceuticals" Companies 1–25 of 189

Extremely Relevant

RegeneRx Biopharmaceuticals, Inc. and Lee’s Pharmaceutical Holdings Ltd.

RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration. RegeneRx currently has three drug candidates in clinical development for ophthalmic, cardiac and dermal indications, three strategic licensing agreements in China, Pan Asia (Korea, Japan, and Australia, among oth...


RegeneRx Pharmaceuticals, Inc.

RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration. RegeneRx currently has three drug candidates in clinical development for ophthalmic, cardiac and dermal indications, three strategic licensing agreements in China, Pan Asia (Korea, Japan, and Australia, among oth...

RegeneRx Biopharmaceuticals Inc.

RegeneRx is focused on the discovery and development of novel peptides to accelerate tissue and organ repair. Currently, RegeneRx is developing three product candidates, RGN-137, RGN-259 and RGN-352 for dermal, ophthalmic, and cardiovascular tissue repair, respectively. These product candidates are based on Tβ4, a synthetic copy of a 43-amino acid, n...


RegeneRx Biopharmaceuticals

RegeneRx is a publicly-traded biopharmaceutical company focused on the discovery and development of novel molecules to accelerate tissue and organ repair. Our stock is traded on the American Stock Exchange (AMEX) under the symbol RGN. We are headquartered in Bethesda, Maryland.RegeneRx utilizes an outsourcing business model in order to effectively control costs while focusing on clinical developme...

Relevant

RegeneRx Biopharmaceuticals, Inc.

RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, or Tβ4, for tissue and organ protection, repair and regeneration. Currently RegeneRx has three products in clinical development. RGN-352 is an injectable formulation to treat cardiovascular and central nervous system diseases, as well as other medical indications....

Itero Biopharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical and commercial advantages over currently marketed alternatives. Itero is led by an executive team with 100+ collective years of successful experience in the development, manufacturi...

Bechtel Group Biopharmaceuticals Production

Design, construction, and validation of facilities for production of human biopharmaceuticals utilizing either fermentation or cell culture, facilities maintenance & operation for the virtual organization, project finance for the efficient conservation of capital, independant analysis of contract manufacturing.

BioRexis Pharmaceutical Corporation

BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercialization due to pharmacological issues. For example, many peptides that are currently approved or in development have a very short half-life, requiring both high and frequent dosing. Unwanted side effects ...

Inspiration Biopharmaceuticals, Inc.

Inspiration Biopharmaceuticals is dedicated exclusively to developing treatments for hemophilia, with a primary mission to broaden access to care, including prophylactic therapy, and improve the treatment of individuals with inhibitor complications. Inspiration has a broad development portfolio, which includes advanced, clinical-stage product candidates for the treatment of hemophilia A and hemop...

Keryx Biopharmaceuticals

Keryx Biopharmaceuticals Incorporated is a drug discovery and development company, that applies KinAce, its proprietary rational drug discovery technology, to genomics data in order to build a rich pipeline of drug candidates targeting protein kinases. Kinases, which play a key role in the way cells communicate, are implicated in a wide range of diseases.

Inspiration Biopharmaceuticals

Inspiration Biopharmaceuticals was founded in 2004 with the mission to revolutionize treatments for hemophilia. The Company is focused on developing products that have the potential to broaden patient access to therapy, including prophylactic use. Greater access and more frequent prophylactic therapy have been shown to reduce complications of the disease and enhance patients' long-term health and ...

Clover Biopharmaceuticals

Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases. Clover is utilizing its proprietary Trimer-Tag© technology platform to develop novel biologics targeting trimerization-depe...

Probably Relevant

Transposagen Biopharmaceuticals, Inc.

Transposagen Biopharmaceuticals, Inc., a Lexington, KY based company, is the worldwide leader in the creation of unique genetically modified rat models. The company's signature products, TKO(TM) Knockout Rat Models and TGEM(TM) Rat Models, mimic human diseases and are used for drug discovery and development research. The company also creates custom transgenic rat models to customer specifications...

XTL Biopharmaceuticals

TL Biopharmaceuticals Ltd. ("XTL") is engaged in the acquisition, development and commercialization of therapeutics for the treatment of neuropathic pain and hepatitis C. XTL is developing Bicifadine, a serotonin and norepinephrine reuptake inhibitor, for the treatment of neuropathic pain. XTL is also developing several novel pre-clinical hepatitis C small molecule inhibitors. XTL also has an acti...

greenovation Biotech GmbH

greenovation is a privately held biotechnology company based in Freiburg, Germany. Venture capital investors are Mediport Venture, Berlin, and the Seed Group, Tuebingen. Incorporated in 1999, the company has developed a safe and cost-effective production platform for complex biopharmaceuticals.greenovation®'s moss bioreactor is a major innovation in the manufacture of biopharmaceuticals including...

SK Biopharmaceuticals

SK Biopharmaceuticals, a research and development company specializing in the discovery of small molecule drug candidates and their development from drug target through commercialization will remain in their headquarters in Fairfield, New Jersey. SK Energy & Chemicals, which manufactures and develops fine chemicals, pharmaceutical intermediates, and API's, will remain in their Fair Lawn, New Jerse...

Watson Pharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. is a San Mateo, California-based specialty biopharmaceutical developer focused on clinically and commercially differentiated protein therapeutics. Itero leverages strategic collaborations to provide capital efficient process and manufacturing development as well as global clinical development and commercialization. The company's management team consists of accomplish...

Accentia Biopharmaceuticals, Inc.

Headquartered in Tampa, Florida, Accentia Biopharmaceuticals, Inc. (OTCQB: “ABPIQ”) is committed to making the autoimmune disease therapy, Revimmune™, available to patients as a comprehensive system of care and drug regimen designed for the treatment of autoimmune diseases.

NGM Biopharmaceuticals, Inc.

XTL Biopharmaceuticals Ltd.

Keryx Biopharmaceuticals, Inc.

Ipsen Biopharmaceuticals Inc.

Sienna Biopharmaceuticals

BioExecutive International™

Building the New Biotech Leadership Every issue of BioExecutive International™ provides biotech executives with a learning experience-an opportunity to understand and implement the business building blocks that will allow them to establish a commercial business from their scienti?c foundations. BioExecutive International™ helps biotech executives to recognize and bridge the intellectual gap be...

Western States Biopharmaceuticals


More From BioPortfolio on "RegeneRx Biopharmaceuticals"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks